SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kilpest India rises with arm entering into alliance with two global experts

11 Sep 2018 Evaluate

Kilpest India is currently trading at Rs. 105.90, up by 1.35 points or 1.29% from its previous closing of Rs. 104.55 on the BSE.

The scrip opened at Rs. 111.50 and has touched a high and low of Rs. 111.50 and Rs. 102.60 respectively. So far 8608 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 179.20 on 09-May-2018 and a 52 week low of Rs. 69.20 on 11-Sep-2017.

Last one week high and low of the scrip stood at Rs. 111.50 and Rs. 87.30 respectively. The current market cap of the company is Rs. 67.86 crore.

The promoters holding in the company stood at 43.42%, while Non-Institutions held 56.58% stake in the company.

Kilpest India’s subsidiary company -- 3B BlackBio Biotech India, Bhopal has entered into a business alliance / MOU with Prof. Subhash Hira, and Prof. Yassa Peirre Yoniene, (These two Global Public Health Experts in infectious diseases, who have occupied senior positions in UN, WHO, USAID, Global Fund, and have been advisors to Ministry of Health (MoH) Zambia, MoH India, MoH Congo).

The alliance is to form a step down subsidiary company in Zambia, a country in South-Central Africa where 51% of the stake will be held by the company’s subsidiary company, 3B BlackBio Biotech India, Bhopal and balance 49% will be held by the two Global Experts.

Kilpest India is one of India’s leading Agri based companies. Kilpest is an ISO certified company and has representation in India in the field of agriculture business comprising Crop Protection Products and Public Health Products, Bio products, Micro-Nutrients and Mix fertilizers.

3B Blackbio Dx Share Price

1384.80 82.15 (6.31%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Lenskart Solutions 540.90
Poly Medicure 1480.80
Laxmi Denta 198.45
Nureca Ltd. 260.25
Hemant Surgical Inds 300.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×